|
CN101426912A
|
|
Chemically modified short interfering nucleic acid molecules that mediate RNA interference
|
|
AU2004200709A1
|
|
Nucleoside Triphosphates and their Incorporation into Ribozymes
|
|
AU2003264633A1
|
|
Nucleic Acid Molecules with Novel Chemical Compositions Capable of Modulating Gene Expression
|
|
US2003207837A1
|
|
Method and reagent for the induction of graft tolerance and reversal of immune responses
|
|
AU2003213203A1
|
|
Rna interference mediated inhibition of myc and myb genes or genes of their respective pathways
|
|
WO03070743A1
|
|
RNA INTERFERENCE MEDIATED INHIBITION OF G72 AND D-AMINO ACID OXIDASE (DAAO) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
AU2003216255A8
|
|
Rna interference mediated inhibition of mdr p-glycoprotein gene expression using short interfering nucleic acid (sina)
|
|
AU2003215161A1
|
|
RNA INTERFERENCE MEDIATED INHIBITION OF TELOMERASE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
AU2003210895A8
|
|
Rna interference mediated inhibition of cyclin d1 gene expression using short interfering nucleic acid (sina)
|
|
US2004102389A1
|
|
Nucleic acid-mediated treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)
|
|
US2003186909A1
|
|
Nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
|
|
AU2002307099A1
|
|
Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies
|
|
EP1386004A2
|
|
Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies
|
|
AU2774202A
|
|
Method and reagent for inhibiting the expression of disease related genes
|
|
CA2442092A1
|
|
Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
|
|
US2003073640A1
|
|
Novel compositions for the delivery of negatively charged molecules
|
|
AU6879501A
|
|
Methods and compositions for treatment of restenosis and cancer using ribozymes
|
|
AU8695901A
|
|
Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives
|
|
US2003092003A1
|
|
Method and reagent for the treatment of Alzheimer's disease
|
|
AU8322201A
|
|
Method and reagent for the inhibition of calcium activated chloride channel-1 (clca-1)
|
